A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and ...

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but imperfect antibiotic candidates into more potent ones. Unlike many existing AI ...

Allied Market Research has published a comprehensive new study titled "Non-Animal Alternative Testing Market by Technology ...

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that Fujirebio Europe N.V. has obtained a CE certificate of the Lumipulse G pTau 217 Plasma assay under the ...

The pharmaceutical industry racked up some of the high-highs and low-lows of the IndustryWeek 500. Some of that drama was just a function of the balance sheet, as companies spun off parts of their ...

OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the ...

The core principle of BETMAT’s Kinetic Chromogenic LAL Assay is based on the specific enzymatic cascade triggered by the interaction between Limulus Amebocyte Lysate (LAL) and bacterial ...

SGS, the world’s leading testing, inspection and certification company, has expanded its analytical capabilities for the Chinese pharmaceutical industry with the introduction of nuclear magnetic ...

The global pharmaceutical industry is at a critical inflection point. While the FDA Modernization Act 2.0 has cleared the ...

Izicopan is an investigational next-generation oral C5aR1 inhibitor designed to achieve differentiated pharmacological properties, with the potential for improved efficacy and safety. The marketed ...

Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

Boston Cell Standards, Inc. (BCS), a private company bringing modern Quality tools and practices to Clinical Immunohistochemistry (IHC) testing worldwide, announced today that its IHC Reference ...